Evaluation of ATx201 as a Topical Antibiotic Agent
NCT03009734
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
73
Enrollment
INDUSTRY
Sponsor class
Conditions
Infection, Bacterial
Interventions
DRUG:
ATx201 dermal formulations 2%
Sponsor
UNION therapeutics